Powered by OpenAIRE graph

View all 1 versions

downloadDownload

Deinobiotics

corporate_fareorganization

Country: France

Deinobiotics

- Funding / Projects
  (1)

1 Projects, page 1 of 1

veRY BEAM (Develop a Partnerships Strategy to ensure key stakeholders, including industry and policy makers, and other networks are engaged and coordinate the alignment of other funded Networks)
assignment_turned_inProjectFrom 2019Partners:Polyphor Ltd, MEMED, VAXDYN SL, Deinobiotics, Septeos SAS +21 partners
Polyphor Ltd,
MEMED,
VAXDYN SL,
Deinobiotics,
Septeos SAS,
Setlance srl,
BEAM ALLIANCE,
AntibioTx (Denmark),
Immunethep SA,
Arsanis Biosciences GmbH,
PHERECYDES,
AiCuris,
Ultupharma AB,
NAB,
Madam Therapeutics,
Debiopharm International,
Phico Therapeutics Ltd,
QURETECH,
Antabio SAS,
Centauri Therapeutics Ltd,
Basilea,
BioVersys AG,
Gedea Biotech (Sweden),
Mutabilis SAS,
Novabiotics Ltd,
Akthelia
Funder: French National Research Agency (ANR) Project Code: ANR-18-JPVR-0001
Funder Contribution: 50,000 EUR
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu